Estrella Immunopharma, Inc. — All Filings
240 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
CERT
CORRESP
DEF 14A
DEFA14A
EFFECT
NT 10-Q
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
SC 13D
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | ANNUAL REPORT | 0001213900-26-029357 | Mar 18, 2026 | Dec 31, 2025 |
| 424B3 | PROSPECTUS | 0001213900-26-016605 | Feb 13, 2026 | — |
| EFFECT | — | 9999999995-26-000279 | Jan 23, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-006410 | Jan 22, 2026 | — |
| S-1/A | REGISTRATION STATEMENT | 0001213900-26-005233 | Jan 16, 2026 | — |
| 8-K | CURREN REPORT | 0001213900-26-003998 | Jan 13, 2026 | Jan 7, 2026 |
| 8-K | CURRENT REPORT | 0001213900-26-001777 | Jan 6, 2026 | Jan 5, 2026 |
| 424B5 | PROSPECTUS SUPPLEMENT | 0001213900-26-001686 | Jan 6, 2026 | — |
| S-1 | REGISTRATION STATEMENT | 0001213900-25-124247 | Dec 22, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-118097 | Dec 4, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-109198 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-107249 | Nov 6, 2025 | Nov 3, 2025 |
| 3 | — | 0001213900-25-094562 | Oct 1, 2025 | Sep 22, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-093197 | Sep 29, 2025 | Sep 23, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-092471 | Sep 26, 2025 | Sep 22, 2025 |
| 10-Q | QUARTERLY REPORT | 0001213900-25-074567 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-072746 | Aug 7, 2025 | Aug 1, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-051361 | Jun 5, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-050329 | Jun 3, 2025 | May 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-048597 | May 29, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-043365 | May 14, 2025 | Mar 31, 2025 |
| 8-K | FORM 8-K | 0001213900-25-039261 | May 2, 2025 | Apr 30, 2025 |
| 10-KT | TRANSITION REPORT | 0001013762-25-002190 | Mar 25, 2025 | Dec 31, 2024 |
| 8-K | CURRRENT REPORT | 0001213900-25-015851 | Feb 21, 2025 | — |
| 8-K | FORM 8-K | 0001213900-25-015364 | Feb 20, 2025 | Feb 19, 2025 |
| 4 | — | 0001213900-25-014310 | Feb 14, 2025 | Oct 30, 2024 |
| 4 | — | 0001213900-25-014306 | Feb 14, 2025 | Oct 30, 2024 |
| S-8 | REGISTRATION STATEMENT | 0001213900-24-111807 | Dec 23, 2024 | — |
| EFFECT | — | 9999999995-24-003843 | Dec 19, 2024 | — |
| CORRESP | — | 0001213900-24-109875 | Dec 17, 2024 | — |
| 424B3 | 424B3 | 0001213900-24-109828 | Dec 17, 2024 | — |
| UPLOAD | — | 0000000000-24-013876 | Dec 17, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-109285 | Dec 16, 2024 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-24-108443 | Dec 12, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-106868 | Dec 9, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-106238 | Dec 6, 2024 | Dec 4, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-103068 | Nov 27, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-102899 | Nov 26, 2024 | Nov 25, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-102134 | Nov 25, 2024 | — |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-099708 | Nov 18, 2024 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-24-098450 | Nov 14, 2024 | Sep 30, 2024 |
| 8-K/A | AMENDMENT TO FORM 8-K | 0001213900-24-095507 | Nov 7, 2024 | Aug 14, 2024 |
| 8-K | CURRENT REPORT | 0001213900-24-095506 | Nov 7, 2024 | Nov 1, 2024 |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-24-091250 | Oct 28, 2024 | Jun 30, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-084717 | Oct 2, 2024 | — |
| 10-K | ANNUAL REPORT | 0001213900-24-082374 | Sep 27, 2024 | Jun 30, 2024 |
| 3 | — | 0001213900-24-072154 | Aug 23, 2024 | Aug 14, 2024 |
| 424B3 | 424B3 | 0001213900-24-071500 | Aug 21, 2024 | — |
| 8-K | CURRENT REPORT | 0001213900-24-071174 | Aug 20, 2024 | Aug 14, 2024 |
| 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-24-065434 | Aug 6, 2024 | — |